UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States

BMJ, 2008-11, Vol.337 (7679), p.a2038-a2038

International edition, 2008

Volltextzugriff (PDF)

Nonmedical Prescription Stimulant Use Among College Students: Why We Need to Do Something and What We Need to Do

Journal of addictive diseases, 2010-10, Vol.29 (4), p.417-426

2010

Volltextzugriff (PDF)

Impairment in Pure and Comorbid Generalized Anxiety Disorder and Major Depression at 12 Months in Two National Surveys

The American journal of psychiatry, 1999-12, Vol.156 (12), p.1915-1923

1999

Volltextzugriff (PDF)

How are addicted physicians treated? A national survey of physician health programs

Journal of substance abuse treatment, 2009-07, Vol.37 (1), p.1-7

2009

Volltextzugriff (PDF)

Setting the standard for recovery: Physicians' Health Programs

Journal of substance abuse treatment, 2009-03, Vol.36 (2), p.159-171

2009

Volltextzugriff (PDF)

Anesthesiologists with Substance Use Disorders: A 5-Year Outcome Study from 16 State Physician Health Programs

Anesthesia and analgesia, 2009-09, Vol.109 (3), p.891-896

2009

Volltextzugriff (PDF)

Medicinal Use of Marijuana

The New England journal of medicine, 2013-02, Vol.368 (9), p.866-868

2013

Volltextzugriff (PDF)

Towards a national model for managing impaired driving offenders

Addiction (Abingdon, England), 2011-07, Vol.106 (7), p.1221-1227

2011

Volltextzugriff (PDF)

Random student drug testing as a school-based drug prevention strategy

Addiction (Abingdon, England), 2013-05, Vol.108 (5), p.839-845

2013

Volltextzugriff (PDF)

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

The journal of clinical psychiatry, 1999-08, Vol.60 (8), p.528-535

1999

Volltextzugriff (PDF)

The Emerging Buprenorphine Epidemic in the United States

Journal of addictive diseases, 2012-01, Vol.31 (1), p.3-7

2012

Volltextzugriff (PDF)

Prescription drugs, drugged driving and per se laws

Injury prevention, 2013-06, Vol.19 (3), p.218-221

2013

Volltextzugriff (PDF)

Prognosis for the recovery of surgeons from chemical dependency: a 5-year outcome study

Archives of surgery (Chicago. 1960), 2011-11, Vol.146 (11), p.1286

2011

Volltextzugriff (PDF)

Can Drug Design Inhibit Abuse?

Journal of psychoactive drugs, 2005-12, Vol.37 (4), p.343-362

2005

Volltextzugriff (PDF)

Prescription Drug Abuse: An Epidemic Dilemma: Addiction and Related Disorders

Journal of psychoactive drugs, 2010, Vol.42 (2), p.127-132

DUPONT, Robert L

2010

Volltextzugriff (PDF)

The Origins of the Minnesota Model of Addiction Treatment-A First Person Account

Journal of addictive diseases, 1999-03, Vol.18 (1), p.107-114

1999

Volltextzugriff (PDF)

Biology and the Environment-Rethinking Demand Reduction

Journal of addictive diseases, 1999-12, Vol.18 (4), p.121-138

Dupont, Robert L.

1999

Volltextzugriff (PDF)

Marijuana and Tobacco: A Major Connection?

Journal of addictive diseases, 2003-01, Vol.22 (3), p.51-62

2003

Volltextzugriff (PDF)

Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder

Journal of clinical psychopharmacology, 2004-04, Vol.24 (2), p.118-125

2004

Volltextzugriff (PDF)

TWELVE-STEP AND MUTUAL-HELP PROGRAMS FOR ADDICTIVE DISORDERS

The Psychiatric clinics of North America, 1999-06, Vol.22 (2), p.425-446

1999

Volltextzugriff (PDF)

Drug testing by urine and hair analysis: complementary features and scientific issues

Forensic science international, 1995-01, Vol.70 (1), p.63-76

1995

Volltextzugriff (PDF)

Drug legalization, harm reduction, and drug policy

Annals of internal medicine, 1995-09, Vol.123 (6), p.461

1995

Volltextzugriff (PDF)

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

Archives of general psychiatry, 1988-05, Vol.45 (5), p.413

1988

Volltextzugriff (PDF)

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety

Archives of general psychiatry, 1988-05, Vol.45 (5), p.423

1988

Volltextzugriff (PDF)

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder

Journal of clinical psychopharmacology, 1992-04, Vol.12 (2), p.96-103

1992

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(118)

Sprache

Englisch
(118)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(118)
Life Sciences & Biomedicine
(95)
Science & Technology
(95)
Humans
(94)
Female
(54)
Male
(51)
Adult
(45)
Middle Aged
(33)
Psychology. Psychoanalysis. Psychiatry
(31)
Infectious Diseases
(25)
Aged
(24)
Pharmacology. Drug Treatments
(24)
Psychopathology. Psychiatry
(24)
General Aspects
(22)
Adolescent
(21)
Travel
(20)
Adult And Adolescent Clinical Studies
(17)
Treatment Outcome
(16)
Bacterial Diseases
(15)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States

Nonmedical Prescription Stimulant Use Among College Students: Why We Need to Do Something and What We Need to Do

Impairment in Pure and Comorbid Generalized Anxiety Disorder and Major Depression at 12 Months in Two National Surveys

How are addicted physicians treated? A national survey of physician health programs

Setting the standard for recovery: Physicians' Health Programs

Anesthesiologists with Substance Use Disorders: A 5-Year Outcome Study from 16 State Physician Health Programs

Medicinal Use of Marijuana

Towards a national model for managing impaired driving offenders

Random student drug testing as a school-based drug prevention strategy

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

The Emerging Buprenorphine Epidemic in the United States

Prescription drugs, drugged driving and per se laws

Prognosis for the recovery of surgeons from chemical dependency: a 5-year outcome study

Can Drug Design Inhibit Abuse?

Prescription Drug Abuse: An Epidemic Dilemma: Addiction and Related Disorders

The Origins of the Minnesota Model of Addiction Treatment-A First Person Account

Biology and the Environment-Rethinking Demand Reduction

Marijuana and Tobacco: A Major Connection?

Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder

TWELVE-STEP AND MUTUAL-HELP PROGRAMS FOR ADDICTIVE DISORDERS

Drug testing by urine and hair analysis: complementary features and scientific issues

Drug legalization, harm reduction, and drug policy

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder

Aktive Filter

Suchergebnisse filtern